Stay updated on Pembrolizumab in Refractory Meningioma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Refractory Meningioma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Refractory Meningioma Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    The page shows a new site revision number (v3.6.6) following an update. This reflects a software/interface update and does not change trial content or data.
    Difference
    0.1%
    Check dated 2026-09-01T18:56:28.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    32 days ago
    Change Detected
    Summary
    The page shows an updated revision tag, changing from v3.6.4 to v3.6.5, indicating a backend/template update for the study page without altering study data or visible content.
    Difference
    0.1%
    Check dated 2026-08-11T17:49:38.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    The page shows revision v3.6.4, replacing v3.6.3, indicating an internal update. The study information and layout remain unchanged.
    Difference
    0.1%
    Check dated 2026-07-28T14:07:27.000Z thumbnail image
  6. Check
    74 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.0 to v3.6.3, reflecting a newer version of the study record page. This update signifies ongoing maintenance of the page's documentation.
    Difference
    0.1%
    Check dated 2026-06-30T01:33:25.000Z thumbnail image
  7. Check
    89 days ago
    Change Detected
    Summary
    The page now reflects that recruitment has ended by noting 'No longer looking for participants,' signaling no active enrollment for this study. In addition, the page adds help-related links (How to Read a Study Record, Common Questions, How to Join a Study) and standardizes the Intervention/Treatment label while updating the revision metadata to v3.6.0.
    Difference
    0.6%
    Check dated 2026-06-15T19:51:14.000Z thumbnail image
  8. Check
    96 days ago
    Change Detected
    Summary
    The page revision was updated from v3.5.4 to v3.5.5, indicating a minor update to the page's content or metadata. This change does not modify the substantive study details or results.
    Difference
    0.1%
    Check dated 2026-06-08T15:41:05.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Refractory Meningioma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Refractory Meningioma Clinical Trial page.